Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|October 14, 2024
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafuspManuel Rodrigues, Toulsie Ramtohul, Aurore Rampanou, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
Science Immunology|February 3, 2023
Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elementsMarianne Burbage, Ares Rocañín-Arjó, Blandine Baudon, et al.
The Journal of Experimental Medicine|April 2, 2024
Divergent local and systemic antitumor response in primary uveal melanomasFrancesca Lucibello, Ana I Lalanne, Anne-Laure Le Gac, et al.
Cancer Discovery|April 3, 2021
Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific NeoepitopesJeremy Bigot, Ana I Lalanne, Francesca Lucibello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 AlterationsManuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
Journal of the National Cancer Institute|December 7, 2023
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variantsMarie-Charlotte Villy, Anaïs Le Ven, Marine Le Mentec, et al.
JAMA Ophthalmology|June 18, 2025
Uveal Melanoma and the Lynch Syndrome Tumor SpectrumAnaïs Le Ven, Marie-Charlotte Villy, André Bortolini Silveira, et al.
Science Translational Medicine|July 12, 2019
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndromeSabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, et al.
Pageof 4